Mitochondrial DNA damage in spinal and bulbar muscular atrophy patients and carriers

Clinica Chimica Acta

Volumn 411, Issue 9-10, 2010, Pages 626-630

  Su, Shihli ^a,g   Jou, Shawhwa ^a   Cheng, Wenling ^a   Lin, Tatsung ^a   Li, Jieyuan ^b   Huang, Chinchang ^c   Lee, Yichung ^d,e   Soong, Bingwen ^d,e   Liu, Chinsan ^a,f  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Androgen receptor; CAG repeat; Mitochondrial DNA; Oxidative stress; SBMA

Indexed keywords

ANDROGEN RECEPTOR; MITOCHONDRIAL DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DNA DAMAGE; FEMALE; GENE FREQUENCY; GENE NUMBER; HUMAN; KENNEDY DISEASE; LEUKOCYTE; MITOCHONDRIAL GENOME; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

ADULT; BIOLOGICAL MARKERS; BULBO-SPINAL ATROPHY, X-LINKED; DEOXYGUANOSINE; DNA DAMAGE; DNA, MITOCHONDRIAL; FEMALE; GENE DELETION; GENOME, MITOCHONDRIAL; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEATS; YOUNG ADULT;

EID: 77950420275     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.12.007     Document Type: Article

References (23)

1. Cha J.H., Dure L.S. Trinucleotide repeats in neurologic diseases: an hypothesis concerning the pathogenesis of Huntington's disease, Kennedy's disease, and spinocerebellar ataxia type I. Life Sci 1994, 54:1459-1464.
2. Beauchemin A.M., Gottlieb B., Beitel L.K., Elhaji Y.A., Pinsky L., Trifiro M.A. Cytochrome c oxidase subunit Vb interacts with human androgen receptor: a potential mechanism for neurotoxicity in spinobulbar muscular atrophy. Brain Res Bull 2001, 56:285-297.
3. Ross C.A. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 2002, 35:819-822.
4. Ranganathan S., Harmison G.G., Meyertholen K., Pennuto M., Burnett B.G., Fischbeck K.H. Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum Mol Genet 2009, 18:27-42.
5. Kang D., Hamasaki N. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer. Curr Med Chem 2005, 12:429-441.
6. Liu C.S., Cheng W.L., Kuo S.J., Li J.Y., Soong B.W., Wei Y.H. Depletion of mitochondrial DNA in leukocytes of patients with poly-Q diseases. J Neurol Sci 2008, 264:18-21.
7. Liu C.S., Tsai C.S., Kuo C.L., et al. Oxidative stress-related alteration of the copy number of mitochondrial DNA in human leukocytes. Free Radic Res 2003, 37:1307-1317.
8. Lin C.S., Wang L.S., Tsai C.M., Wei Y.H. Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapy. Interact Cardiovasc Thorac Surg 2008, 7:954-958.
9. Chen S.S., Wu S.B., Wei Y.H. The difference in oxidative stress of the blood between using 5% glucose water and distilled water as the irrigant for BPH patients undergoing transurethral resection of the prostate. World J Urol 2010, 28:33-37.
10. Tsai H.F., Liu C.S., Leu T.M., et al. Analysis of trinucleotide repeats in different SCA loci in spinocerebellar ataxia patients and in normal population of Taiwan. Acta Neurol Scand 2004, 109:355-360.
11. Liu C.S., Chang Y.C., Chen D.F., et al. Type IV hyperlipoproteinemia and moderate instability of CAG triplet expansion in the androgen-receptor gene. Lipid, sex hormone and molecular study in a Chinese family with Kennedy-Alter-Sung disease. Acta Neurol Scand 1995, 92:398-404.
12. Liu C.S., Cheng W.L., Lee C.F., et al. Alteration in the copy number of mitochondrial DNA in leukocytes of patients with mitochondrial encephalomyopathies. Acta Neurol Scand 2006, 113:334-341.
13. Tsai H.F., Tsai H.J., Hsieh M.L. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells. Biochem Biophys Res Commun 2004, 324:1274-1282.
14. Gardian G., Vecsei L. Huntington's disease: pathomechanism and therapeutic perspectives. J Neural Transm 2004, 111:1485-1494.
15. Moraes C.T., DiMauro S., Zeviani M., et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989, 320:1293-1299.
16. Lee H.C., Wei Y.H. Mutation and oxidative damage of mitochondrial DNA and defective turnover of mitochondria in human aging. J Formos Med Assoc 1997, 96:770-778.
17. Zhang J., Montine T.J., Smith M.A., et al. The mitochondrial common deletion in Parkinson's disease and related movement disorders. Parkinsonism Relat Disord 2002, 8:165-170.
18. Horton T.M., Graham B.H., Corral-Debrinski M., et al. Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington's disease patients. Neurology 1995, 45:1879-1883.
19. Acevedo-Torres K., Berríos L., Rosario N., et al. Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease. DNA Repair (Amst) 2009, 8:126-136.
20. Mariotti C., Castellotti B., Pareyson D., et al. Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul Disord 2000, 10:391-397.
21. Kristiansen M., Knudsen G.P., Tanner S.M., et al. X-inactivation patterns in carriers of X-linked myotubular myopathy. Neuromuscul Disord 2003, 13:468-471.
22. Chen R.S., Huang C.C., Chu N.S., Cheng C.C., Wei Y.H. Random X chromosome methylation patterns in the carriers with clinical phenotypic expressions of X-linked recessive bulbospinal neuronopathy. Acta Neurol Scand 1999, 100:249-253.
23. Paradas C., Solano F., Carrillo F., et al. Highly skewed inactivation of the wild-type X-chromosome in asymptomatic female carriers of spinal and bulbar muscular atrophy (Kennedy's disease). J Neurol 2008, 255:853-857.